Por: Ars Technica Science October 14, 2022
Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 14, 2022 2:02 pm UTC Mike Kemp/Getty Images Share this story At the end of September, a spot of good news: Relyvrio, a new drug for treating amyotrophic lateral sclerosis—or ALS, a neurological disorder without a cure—was approved in the United States. The ALS community rejoiced; the... + full article
Forbes USA Business October 13, 2022
This story appears in the October 2022 issue of Forbes Asia. Dilip SuranaCourtesy of Dilip Surana This story is part of Forbes’ coverage of India’s Richest 2022. See the full list . , the brothers who own generic drugs maker , saw their wealth rise 44% to $3.25 billion as... + más
Bay Leaf Authentic Indian Cuisine places priority on tradition and authenticity | The Advocate
Council Post: How Social Media Analytics Is Transforming Pharma Decision Making | Forbes
The Hill USA Health October 10, 2022
The National Gallery of Art is now by Dutch painter Johannes Vermeer — of “Girl with a Pearl Earring” fame — though it turns out they never had four to begin with. In health news, Senate Republicans are eyeing a repeal of Democrats’ drug pricing law, citing... + más
Council Post: Putting Pricing Strategy As A Centerpiece Of Your Business | Forbes
Disney World ups the price of Genie+ skip-the-line service | Orlando Sentinel
The Hill USA Politics October 08, 2022
Senate Republicans on Friday introduced a bill that would roll back the drug pricing reforms included in the sweeping Inflation Reduction Act, including the measures allowing Medicare to negotiate drug prices and capping annual drug expenses for many seniors. Republican Sens.... + más
McConnell backs Senate's election reform bill, calls Cheney-backed plan a 'non-starter' | Fox News
Los Angeles Times USA Opinion October 02, 2022
If you’re a woman or person of color, your health is being hurt by a lack of diversity in healthcare. I suddenly realized that a few years ago at a conference for pharma executives. Dr. Lynn Seely, who was then the female chief executive officer of Myovant, a biopharmaceutical... + más
Council Post: How A Diverse Board Can Help Your Company | Forbes
Jody Rose and Jeff Bussgang are tackling tech’s diversity problem | The Boston Globe
Forbes USA Business September 30, 2022
, VP and Business Leader, Infovision Social—the Research, Digital Experience, Social Media Analytics arm of InfoVision. getty Social media has opened up a whole new dimension of insights for pharma companies. The conversations happening in social media are real-world... + más
Council Post: 10 Areas To Dedicate The Bulk Of Your Social Media Budget To (And Why) | Forbes
Cadence Brings Big Data And AI Analytics To SoC Verification | Forbes
CNBC USA Health September 29, 2022
The Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig's disease, a victory for patients and advocates despite limited evidence that the drug is effective.The drug, from the Massachusetts-based , joins... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | ABC News
PennLive USA Opinion September 25, 2022
By Bill Johnston-WalshHere in Pennsylvania and across the country, millions of seniors will get relief from a new law that will help reduce out-of-control drug prices. For the first time in decades, Big Pharma’s relentless grip on their wallets, medicine cabinets and peace of... + más
Medicare premiums will drop next year. Here's how much you'll save. | CBS News
FDA approves controversial new drug designed to slow the progression of ALS | CNBC
About iurex | Privacy Policy | Disclaimer |